These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 13992335)

  • 21. Genital and urinary tract diseases and prostate cancer risk.
    Pelucchi C; Talamini R; Negri E; Franceschi S; La Vecchia C
    Eur J Cancer Prev; 2006 Jun; 15(3):254-7. PubMed ID: 16679869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Benign prostatic hyperplasia (BPH) and prostatitis: prevalence of painful ejaculation in men with clinical BPH.
    Nickel JC; Elhilali M; Vallancien G;
    BJU Int; 2005 Mar; 95(4):571-4. PubMed ID: 15705082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of prostatic massage on serum complexed prostate-specific antigen levels.
    Tarhan F; Orçun A; Küçükercan I; Camursoy N; Kuyumcuoğlu U
    Urology; 2005 Dec; 66(6):1234-8. PubMed ID: 16360449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The application of botulinum toxin in the prostate.
    Chuang YC; Chancellor MB
    J Urol; 2006 Dec; 176(6 Pt 1):2375-82. PubMed ID: 17085104
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
    Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
    J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Use of cernilton in the therapy of prostatic adenoma and chronic prostatitis].
    Shaplygin LV; Sivakov AA
    Urologiia; 2007; (3):35-7, 39. PubMed ID: 17722618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Vitaprost forte efficacy in patients with prostatic adenoma].
    Tkachuk VN; Tkachuk IN
    Urologiia; 2008; (4):34-7. PubMed ID: 19058362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prostate specific antigen and diagnosis of prostate cancer].
    Rigaud J; Bouchot O
    Rev Prat; 2003 Dec; 53(20):2229-36. PubMed ID: 15018076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential expression profile of cold (TRPA1) and cool (TRPM8) receptors in human urogenital organs.
    Du S; Araki I; Kobayashi H; Zakoji H; Sawada N; Takeda M
    Urology; 2008 Aug; 72(2):450-5. PubMed ID: 18384850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Post-prostatic massage examination for prediction of asymptomatic prostatitis in needle biopsies: a prospective study.
    Tekin A; Yuksel A; Tekin S; Gumrukcu G; Aslan AR; Sengor F
    J Urol; 2009 Aug; 182(2):564-8; discussion 568-9. PubMed ID: 19524953
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Further studies on the relationship between benign prostatic hyperplasia and prostatitis].
    Xia T
    Zhonghua Nan Ke Xue; 2004 Feb; 10(2):83-5. PubMed ID: 15027176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of AgNOR count and its correlation with serum PSA levels in prostatic lesions.
    Goel T; Garg S
    Urol Int; 2009; 82(3):286-90. PubMed ID: 19440015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How does the pre-massage and post-massage 2-glass test compare to the Meares-Stamey 4-glass test in men with chronic prostatitis/chronic pelvic pain syndrome?
    Nickel JC; Shoskes D; Wang Y; Alexander RB; Fowler JE; Zeitlin S; O'Leary MP; Pontari MA; Schaeffer AJ; Landis JR; Nyberg L; Kusek JW; Propert KJ
    J Urol; 2006 Jul; 176(1):119-24. PubMed ID: 16753385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Examination of the relationship between symptoms of prostatitis and histological inflammation: baseline data from the REDUCE chemoprevention trial.
    Nickel JC; Roehrborn CG; O'leary MP; Bostwick DG; Somerville MC; Rittmaster RS
    J Urol; 2007 Sep; 178(3 Pt 1):896-900; discussion 900-1. PubMed ID: 17632164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Efficacy of vitaprost forte in patients with prostatic adenoma].
    Miller AM; Iaroshenko VP; Soroka PV; Stakhnev EIu
    Urologiia; 2008; (5):50, 52-4. PubMed ID: 19069497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Expression of Ki-67, Bcl-2,Bax and caspase-3 in benign prostatic hyperplasia combined with prostatitis and their significances].
    Wang L; Yang JR; Yang LY; Liu ZT; Rao JM; Liu LF
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Mar; 33(3):222-6. PubMed ID: 18382056
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Changes in microcirculation of the urinary bladder in patients with stage II prostatic adenoma depending on the treatment method].
    Pavlov VN; Kazikhinurov AA; Ishemgulov RR; Mustafin AT
    Urologiia; 2008; (1):31-2, 34-5. PubMed ID: 18649676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Etiology and treatment of bladder spasm associated with benign prostatic hyperplasia].
    Zhao J; He DL; Liu RM; Wang MZ; Wang XN; Xing JP; Nan XY
    Zhonghua Nan Ke Xue; 2005 Apr; 11(4):275-7. PubMed ID: 15921258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Eviprostat suppresses proinflammatory gene expression in the prostate of rats with partial bladder-outlet obstruction: a genome-wide DNA microarray analysis.
    Tagaya M; Oka M; Ueda M; Takagaki K; Tanaka M; Ohgi T; Yano J
    Cytokine; 2009 Sep; 47(3):185-93. PubMed ID: 19616448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A mathematical model for the proliferation of bacteria in the urinary bladder due to enlarged prostate.
    Moxnes JF; Hausken K
    Med Hypotheses; 2006; 67(6):1391-9. PubMed ID: 16860489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.